Related Experiment Videos
ECT emergence agitation and methohexital-succinylcholine interaction. Case report
1Department of Psychiatric Medicine, East Carolina University School of Medicine, Greenville, North Carolina 27858-4354.
General Hospital Psychiatry
|September 1, 1993
Summary
Two methods, increasing succinylcholine dose or adding methohexital, can prevent post-electroconvulsive therapy (ECT) emergence agitation. These strategies are effective individually or combined, without impacting ECT efficacy.
Area of Science:
- Anesthesiology
- Neuroscience
- Psychiatry
Background:
- Electroconvulsive therapy (ECT) is an effective treatment for severe psychiatric disorders.
- Emergence agitation is a common and distressing side effect following ECT.
- Managing post-ECT agitation is crucial for patient comfort and safety.
Observation:
- Two distinct interventions were evaluated for preventing emergence agitation after ECT.
- The first method involved optimizing the succinylcholine dose to approximately 1.1 mg/kg.
- The second method incorporated a methohexital bolus of roughly 0.67 mg/kg administered at seizure termination.
Findings:
- Both increasing the succinylcholine dose and administering a methohexital bolus effectively reduced post-ECT emergence agitation.
- These two methods demonstrated additive effects when used concurrently.
- Neither intervention was found to diminish the therapeutic efficacy of the ECT treatment.
Implications:
- These findings offer practical strategies for anesthesiologists and psychiatrists to improve the ECT recovery process.
- Optimized pharmacologic management can enhance patient experience and reduce the need for additional interventions.
- Further research may explore the combined use of these and other agents for comprehensive post-ECT care.